Skip to main content

Table 1 Baseline characteristics and biochemical parameters before and after PD

From: Peritoneal dialysis assists residual renal function to maintain glucose tolerance: a prospective observational study

Variables ESRD (n = 20)
Non-diabetic
(n = 14)
Diabetic
(n = 6)
Age (years) 58.07 ± 12.85 58.17 ± 7.17
Sex (male/female) 11/3 6/0
BMI (kg/m2) 23.54 ± 2.90 29.76 ± 6.42
Antihypertensive agents
 ARB/ACE inhibitor 6 (42.86 %) 6 (100 %)
 Ca channel blocker 12 (85.71 %) 4 (66.67 %)
Hypoglycemic drugs
 Insulin   4 (66.67 %)
 Dpp-4 inhibitor   1 (16.67 %)
 Sulfonylurea   0 (0 %)
 α-GI   2 (33.33 %)
Biochemical parameters Before PD After PD Before PD After PD
 Total protein (mg/dL) 6.02 ± 0.98 6.39 ± 0.71* 5.60 ± 0.86 6.17 ± 0.50*
 Albumin (g/dL) 3.38 ± 0.75 3.43 ± 0.59 2.93 ± 0.62 3.15 ± 0.56
 BUN (mg/dL) 71.64 ± 16.70 53.08 ± 11.64** 67.47 ± 20.76 48.10 ± 12.62**
 Creatinine (mg/dL) 10.90 ± 3.93 9.96 ± 3.46* 10.50 ± 1.85 10.08 ± 2.21
 e-GFR (mL/min/1.73 m2) 4.89 ± 1.91   4.84 ± 1.39  
 HbA1c (%) 5.33 ± 0.33 5.58 ± 0.39 6.22 ± 1.32 6.43 ± 1.25
 GA (%) 15.60 ± 4.18 16.90 ± 3.41 15.84 ± 2.78 16.20 ± 3.05
 WBC (103/μL) 6.38 ± 1.65 6.01 ± 1.14 7.85 ± 1.84 7.43 ± 1.45
 Hb (g/dL) 9.80 ± 1.08 10.40 ± 0.87 10.12 ± 0.87 11.08 ± 0.70*
 CRP (mg/dL) 0.14 ± 0.13 0.37 ± 0.63 0.52 ± 0.90 0.35 ± 0.46
  1. Results are shown as mean ± SD
  2. ESRD end-stage renal disease, BMI body mass index, ACE angiotensin-converting enzyme, ARB angiotensin-receptor blocker, Dpp-4 inhibitor dipeptidyl peptidase 4 inhibitor, α-GI α-glucosidase inhibitor, BUN blood urea nitrogen, e-GFR estimated glomerular filtration rate, HbA1c hemoglobin A1c, GA glycoalbumin, WBC white blood cell, Hb hemoglobin, CRP, C-reactive protein
  3. **p < 0.01 vs. before PD; *p < 0.05 vs. before PD